U.S. flag

An official website of the United States government

GRCh37/hg19 22q13.31-13.33(chr22:48223839-51197725)x1 AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
May 26, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001007506.2

Allele description [Variation Report for GRCh37/hg19 22q13.31-13.33(chr22:48223839-51197725)x1]

GRCh37/hg19 22q13.31-13.33(chr22:48223839-51197725)x1

Genes:
Variant type:
copy number loss
Cytogenetic location:
22q13.31-13.33
Genomic location:
Chr22: 48223839 - 51197725 (on Assembly GRCh37)
Preferred name:
GRCh37/hg19 22q13.31-13.33(chr22:48223839-51197725)x1
HGVS:
NC_000022.10:g.(?_48223839)_(51197725_?)del

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001167128Quest Diagnostics Nichols Institute San Juan Capistrano
criteria provided, single submitter

(ACMG/ClinGen CNV Guidelines, 2019)
Pathogenic
(May 26, 2023)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen).

Riggs ER, Andersen EF, Cherry AM, Kantarci S, Kearney H, Patel A, Raca G, Ritter DI, South ST, Thorland EC, Pineda-Alvarez D, Aradhya S, Martin CL.

Genet Med. 2020 Feb;22(2):245-257. doi: 10.1038/s41436-019-0686-8. Epub 2019 Nov 6. Erratum in: Genet Med. 2021 Nov;23(11):2230.

PubMed [citation]
PMID:
31690835
PMCID:
PMC7313390

Details of each submission

From Quest Diagnostics Nichols Institute San Juan Capistrano, SCV001167128.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

Deletions of chromosome 22q13.3, including SHANK3 (OMIM 606230), are associated with Phelan-McDermid syndrome (PHMDS; 22q13.3 deletion syndrome; OMIM 606232). The SHANK3 gene has been deleted in all reported cases with Phelan-McDermid syndrome (Phelan K, Rogers RC. Phelan-McDermid Syndrome. 2005 May 11 [GeneReviews [Internet]. available from: https://0-www-ncbi-nlm-nih-gov.brum.beds.ac.uk/books/NBK1198/.; Phelan K and McDermid HE. The 22q13.3 Deletion Syndrome (Phelan-McDermid Syndrome). Mol Syndromol. 2012;2(3-5):186-201).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 4, 2024